eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2020
vol. 36
 
Share:
Share:
abstract:
Review paper

Interruption of anticoagulation in patients undergoing elective surgical procedures

Agnieszka Łętek
1, 2
,
Łukasz Zandecki
1, 2
,
Agnieszka Janion-Sadowska
1
,
Anna Polewczyk
1, 2

1.
II Clinic of Cardiology, Regional Polyclinical Hospital, Kielce Region Centre of Cardiology, Kielce, Poland
2.
Department of Physiology, Pathophysiology and Clinical Immunology, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Medical Studies/Studia Medyczne 2020; 36 (1): 51–59
Online publish date: 2020/03/31
View full text Get citation
 
PlumX metrics:
Interruption of long-term therapy with oral anticoagulants in patients undergoing elective surgical procedures is a common problem in clinical practice. A large number of patients are receiving oral anticoagulants due to atrial fibrillation, mechanical prosthetic valves, or thromboembolic disease. Each year many of these patients will undergo an invasive procedure. The most important aspect is the risk-benefit assessment: the general risk of bleeding related to the procedure, additional risk of bleeding during the procedure related to anticoagulants, and on the other hand the risk of thrombotic complications such as ischaemic stroke or coronary stent thrombosis, associated with discontinuation of the antithrombotic therapy. The aim of the article is to present the management of anticoagulant therapy in patients undergoing elective surgical procedures.
keywords:

oral anticoagulants, surgical procedures, thromboembolic risk, risk of bleeding

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.